Radeberg, Germany Clinical Trials

A listing of Radeberg, Germany clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 73 clinical trials
Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat

MDS/AML with MRD and impending relapse after allogeneic stem cell transplantation and/or conventional chemotherapy

Medizinischen Klinik und Poliklinik I / H matologie, Universit tsklinikum Carl Gustav Carus an der Technischen Universit t Dresden
 (8.8 away) Contact site
  • 05 May, 2021
  • +13 other locations
ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

A prospective Phase II clinical study to assess the efficacy and toxicity of high dose chemotherapy (HDT) followed by allogeneic stem cell transplantation (allo- or autoSCT) as treatment of primary progressive and relapsed aggressive Non-Hodgkin Lymphoma (NHL) - ASTRAL

Universit tsklinikum Carl Gustav Carus Dresden, Medzinische Klinik I
 (8.8 away) Contact site
  • 01 Aug, 2021
  • +12 other locations
Dose Escalation Study of Cabozantinib for Advanced HCC Patients With Compensated Liver Cirrhosis

Open-label, single arm, multicenter phase II trial assessing the tolerability of a reduced starting dose of 40 mg cabozantinib for 4 weeks and subsequent dose escalation to 60 mg cabozantinib until disease progression or intolerable toxicities.

BAG / Onkologische Gemeinschaftspraxis
 (7.4 away) Contact site
  • 25 Feb, 2021
  • +6 other locations
Stereotactical Photodynamic Therapy With 5-aminolevulinic Acid (Gliolan ) in Recurrent Glioblastoma

In this multicenter, randomized, non-blinded trial the efficacy and safety of stereotactical photodynamic therapy with 5-aminolevulinic acid will be investigated in 106 patients with recurrent glioblastoma.

Medizinische Fakult t Carl Gustav Carus, Klinik und Poliklinik f r Neurochirurgie
 (7.4 away) Contact site
  • 27 Apr, 2021
  • +4 other locations
Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Patients with moderate to severe COVID-19 present a very high risk of thromboembolic disease.This multicenter, prospective, randomized, event-driven study evaluates rivaroxaban compared with standard of care including low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) at prophylactic doses if applicable in the prevention of the composite of venous thromboembolism (deep vein …

Medical Clinic I. Universit tsklinikum Carl Gustav Carus, Dresden
 (7.4 away) Contact site
  • 23 Jun, 2021
  • +33 other locations
A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail

This study will be a multicenter, international, randomized, vehicle-controlled, parallel-group, double-blinded study. Subjects who are eligible to participate with a confirmed diagnosis of Distal Subungual onychomycosis (DSO) of the toenail will be randomized and participate in one of the following treatment groups: BB2603-1: 0.01% terbinafine/0.03% polyhexanide formulation, or BB2603-3: 0.03% …

Uniklink Carl Gustav Carus, Klinik und Polyklinik f r Dermatologie
 (8.8 away) Contact site
  • 26 Apr, 2021
  • +24 other locations
Inhibition of Rho Kinase (ROCK) With Fasudil as Disease-modifying Treatment for ALS

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder and therapeutic options are limited. The rho kinase (ROCK) inhibitor Fasudil was shown to be neuroprotective, induced axonal regeneration and improved survival and behavioral outcome in models of ALS and other neurodegenerative diseases. The aim of this phase IIa, multi-center and …

Universit tsklinikum Carl Gustav Carus Dresden
 (7.4 away) Contact site
  • 26 Jan, 2021
  • +13 other locations
A Study to Evaluate the Efficacy Safety Tolerability and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation

A randomized, placebo-controlled, investigator- and participant-blinded study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of HSY244 in participants with AF.

anticoagulation therapy
body mass index
Novartis Investigative Site
 (7.4 away) Contact site
  • 30 Jul, 2021
  • +6 other locations
Newton Study (NEW Dosing mainTenance Therapy Ovarian caNcer)

This study evaluates whether the adoption of the RADAR dosing strategy could further reduce treatment related toxicities improving the safety profile of niraparib.

neutrophil count
direct bilirubin
peritoneal cancer
ovarian cancer
University Hospital Dresden
 (8.8 away) Contact site
  • 20 Jun, 2021
  • +11 other locations
A Study to Assess Efficacy and Safety of Eltrombopag in Combination With a Short Course of Dexamethasone in Patients With Newly Diagnosed ITP

The purpose of this study is to compare the ability of eltrombopag in combination with a short course of high-dose dexamethasone to induce sustained response off treatment in patients with newly-diagnosed ITP versus 1-3 cycles of dexamethasone monotherapy. The unmet clinical need and the potential for eltrombopag when added to …

platelet count
Novartis Investigative Site
 (7.4 away) Contact site
  • 02 Jul, 2021
  • +19 other locations